Deloitte November 30, 2018
Luis Hakim, Sonal Shah

The medtech industry is under pressure: From tight margins and the shift to value-based payment models to advances in digital technology, many R&D leaders are taking a fresh look at investment strategies.

Executive summary

MOST medtech companies are under pressure to improve efficiency and reduce costs in an environment where health systems, patients, and payers require increasing levels of evidence to justify product value and reimbursement. At the same time, innovation in payment models and advances in sensors and digital technologies are creating new opportunities to advance patient care and improve development efficiency. Technology advances can also create competitive threats from nontraditional entrants.

The key findings from the survey are:

  • R&D leaders are responding to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Healthcare System, Insurance, Investments, Market Research, Payment Models, Provider, Technology, Trends, Value Based
The Ripple Effect: Ways to Make Health in All Policies Stick in Kansas and Beyond to Enhance Health and Equity
Katie Couric Talks Colon Cancer, Health Equity And AI
Ernst & Young: Health equity efforts maturing, but data capabilities remain barrier
Research Funding Is Needed To Support An Effective, Equitable, And Sustainable Public Health System
Covid’s scientific silver lining: A chance to watch the human immune system respond in real time

Share This Article